Literature DB >> 7680714

Plasma protein binding of tacrolimus in humans.

W Piekoszewski1, W J Jusko.   

Abstract

An ultracentrifugation method was used for the determination of the tacrolimus (FK 506) free fraction in plasma. Samples of 400 microL were centrifuged for 6 h at 160,000 x g, and concentrations of [3H]tacrolimus were measured in the original plasma and in the second layer of the supernatant. The binding of tacrolimus in normal plasma averaged 73% and was independent of the drug concentration. Albumin (3.5%) binding averaged 44.4-57.0%, and alpha 1-acid glycoprotein (100 mg/L) binding averaged 39%. Hepatic transplant patients exhibited 72.0% +/- 3.6% binding of tacrolimus. Plasma protein binding is probably not an important factor in the disposition of tacrolimus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680714     DOI: 10.1002/jps.2600820325

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Use of dried blood spots in drug development: pharmacokinetic considerations.

Authors:  Malcolm Rowland; Gary T Emmons
Journal:  AAPS J       Date:  2010-04-10       Impact factor: 4.009

Review 2.  Interpreting tacrolimus concentrations during pregnancy and postpartum.

Authors:  Mary F Hebert; Songmao Zheng; Karen Hays; Danny D Shen; Connie L Davis; Jason G Umans; Menachem Miodovnik; Kenneth E Thummel; Thomas R Easterling
Journal:  Transplantation       Date:  2013-04-15       Impact factor: 4.939

Review 3.  Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients.

Authors:  P E Wallemacq; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 4.  Drug interactions with tacrolimus.

Authors:  Teun van Gelder
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Tacrolimus placental transfer at delivery and neonatal exposure through breast milk.

Authors:  Songmao Zheng; Thomas R Easterling; Karen Hays; Jason G Umans; Menachem Miodovnik; Shannon Clark; Justina C Calamia; Kenneth E Thummel; Danny D Shen; Connie L Davis; Mary F Hebert
Journal:  Br J Clin Pharmacol       Date:  2013-12       Impact factor: 4.335

6.  Plasma Exchange and Immunoadsorption of Patients with Thoracic Organ Transplantation.

Authors:  Silke Rummler; Dagmar Barz
Journal:  Transfus Med Hemother       Date:  2012-07-20       Impact factor: 3.747

7.  Pharmacokinetics of tacrolimus during pregnancy.

Authors:  Songmao Zheng; Thomas R Easterling; Jason G Umans; Menachem Miodovnik; Justina C Calamia; Kenneth E Thummel; Danny D Shen; Connie L Davis; Mary F Hebert
Journal:  Ther Drug Monit       Date:  2012-12       Impact factor: 3.681

Review 8.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

9.  Factors affecting variability in distribution of tacrolimus in liver transplant recipients.

Authors:  H Zahir; G McCaughan; M Gleeson; R A Nand; A J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

10.  Unbound Plasma, Total Plasma, and Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation.

Authors:  Maaike A Sikma; Erik M Van Maarseveen; Claudine C Hunault; Javier M Moreno; Ed A Van de Graaf; Johannes H Kirkels; Marianne C Verhaar; Jan C Grutters; Jozef Kesecioglu; Dylan W De Lange; Alwin D R Huitema
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.